Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CNS drug discovery: challenges and solutions.

Alan M Palmer1, F Anne Stephenson

  • 1Society for Medicines Research, London, UK. alan.palmer@pharmidex.com

Drug News & Perspectives
|March 9, 2005
PubMed
Summary

The central nervous system (CNS) drug market is growing due to an aging population. This symposium explored innovative strategies for CNS research and development challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of cell surface expression of GABA<sub>A</sub> receptors by a conserved region at the end of the N-terminal extracellular domain of receptor subunits.

The Journal of biological chemistry·2022
Same author

A half century of γ-aminobutyric acid.

Brain and neuroscience advances·2020
Same author

The role of mouse tumour models in the discovery and development of anticancer drugs.

British journal of cancer·2019
Same author

Identification of C-Terminal Binding Protein 1 as a Novel NMDA Receptor Interactor.

Neurochemical research·2018
Same author

Developmental changes in trak-mediated mitochondrial transport in neurons.

Molecular and cellular neurosciences·2017
Same author

APLP1 and APLP2, members of the APP family of proteins, behave similarly to APP in that they associate with NMDA receptors and enhance NMDA receptor surface expression.

Journal of neurochemistry·2015

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Discovery

Background:

  • The global market for central nervous system (CNS) disorder therapies was valued at approximately $50 billion in 2001.
  • Projected market growth is driven by the aging "baby boomer" population, increasing demand for advanced CNS medicines.
  • A symposium on September 23, 2004, in London convened over 100 delegates to address CNS research and development challenges.

Framework:

  • Identifying and validating novel drug targets for CNS disorders.
  • Assessing drug penetration across the blood-brain barrier (BBB) using in vitro and in vivo models.
  • Developing in silico methods to predict BBB permeability for enhanced drug design.

Implementation:

  • Evaluating therapeutic efficacy through in vitro and in vivo experimental approaches.
  • Establishing reliable biomarkers to guide decision-making processes in CNS drug development.
  • Leveraging magnetic resonance imaging (MRI) techniques for effective CNS drug discovery.

Implications:

  • Addressing key challenges in CNS research and development through innovative strategies.
  • Facilitating the discovery of safer and more effective treatments for CNS disorders.
  • Contributing to the advancement of the growing CNS therapeutics market.

Related Experiment Videos